Capital Ventures Private Limited
FDA import alert and refusal historyDelhi, IndiaFEI 3007313144
As of October 26, 2026, Capital Ventures Private Limited (Delhi, India) is on the red list of FDA Import Alert 99-08 (Processed human and animal foods: pesticides) for aged basmati rice, published by FDA on January 14, 2025, and has 2 FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-08 · red list
- Last import refusal
- Rice, basmati, processed (packaged) · PESTICIDE
- Last warning letter
- None found
- Last inspection
- Classified NAI (No Action Indicated)
Every FDA record for Capital Ventures Private Limited
4 records, newest first. Each line links to the FDA page it came from.
2025
- Import alert listingListed on Import Alert 99-08red listAged Basmati RiceSource
2018
2017
- InspectionInspection classified NAI (No Action Indicated)Foodborne Biological HazardsSource
- Import refusalRefused, Flours and meals n.e.c.USUAL NAMEALLERGENEntry H77-0158268-3Source
Refusal charges, in plain English
- ALLERGEN1 refused line
Major food allergen not declared
The label appeared not to declare all major food allergens present in the product, as section 403(w) of the FD&C Act requires.
- PESTICIDE1 refused line
Pesticide chemical residue
The product appeared to contain a pesticide chemical residue that makes it adulterated under section 402(a)(2)(B) of the FD&C Act, for example a residue above the U.S. tolerance or one with no U.S. tolerance for that food.
- USUAL NAME1 refused line
Common or usual name missing
The label appeared not to show the common or usual name of the food.
Questions about Capital Ventures Private Limited
- Is Capital Ventures Private Limited on an FDA import alert?
- Yes. As of October 26, 2026, Capital Ventures Private Limited is on the red list of FDA Import Alert 99-08, “Processed human and animal foods: pesticides”, for aged basmati rice; FDA published the listing on January 14, 2025.
- Has FDA refused shipments from Capital Ventures Private Limited?
- Yes. FDA refused 2 shipment lines from Capital Ventures Private Limited between January 19, 2017 and January 22, 2018. The most recent, on January 22, 2018, was rice, basmati, processed (packaged), charged as PESTICIDE (pesticide chemical residue).
- Why did FDA refuse Capital Ventures Private Limited's shipments?
- The most frequent charges are ALLERGEN (major food allergen not declared, 1 line) and PESTICIDE (pesticide chemical residue, 1 line).
- When was Capital Ventures Private Limited last inspected by FDA?
- FDA's most recent inspection of Capital Ventures Private Limited with a final classification is dated September 1, 2017 and was classified NAI (No Action Indicated).
- What is Capital Ventures Private Limited's FEI number?
- Capital Ventures Private Limited's FDA Establishment Identifier (FEI) is 3007313144.
- Can shipments from Capital Ventures Private Limited still enter the U.S.?
- Shipments of aged basmati rice from Capital Ventures Private Limited can be detained without physical examination under Import Alert 99-08; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Capital Ventures Private Limited?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.